Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents-Reference-Cited by-同舟云学术

Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents

Published:2017-05-19 Issue:2 Volume:56 Page:197-206
ISSN:1369-3786
Container-title:Medical Mycology
language:en
Short-container-title:

Author:

Kim Si-Hyun¹²³,Choi Jae-Ki¹²,Cho Sung-Yeon¹²⁴,Lee Hyo-Jin¹²,Park Sun Hee¹²,Choi Su-Mi¹²,Lee Dong-Gun¹²⁴,Choi Jung-Hyun¹²³,Yoo Jin-Hong¹²,Lee Jong-Wook⁴

Affiliation:

1. Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

2. Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

3. Division of Infectious Diseases, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

4. Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine

Link

http://academic.oup.com/mmy/article-pdf/56/2/197/24365903/myx038.pdf

Reference30 articles.

1. Up to date epidemiology, diagnosis and management of invasive fungal infections;Oren;Clin Microbiol Infect,2014

2. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: A single-centre study with focus on emerging pathogens;Corzo-Leon;Mycoses,2015

3. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies;Gamaletsou;Clin Microbiol Infect,2014

4. Changing epidemiology of systemic fungal infections;Richardson;Clin Microbiol Infect,2008